Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 HR+/HER2- Early Breast Cancer 1 HR+/HER2+ Early Breast Cancer 1 Endometrial Stromal Tumors 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HR+/HER2- Early Breast Cancer × Aromatase Inhibitors × Clear all

NCT07616453 2026-06-01

TAYLOR-002

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

HR+/HER2- Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡